At the 52nd annual meeting of the American Society of Hematology, which wraps up Tuesday, Novartis, Celgene and Seattle Genetics revealed the latest news from their studies on blood diseases and cancers. But despite some positive results, all three had down days in the stock market.
Continue reading Novartis, Seattle Genetics, Celgene Reveal Latest News on Blood Disease Drugs
Novartis, Seattle Genetics, Celgene Reveal Latest News on Blood Disease Drugs originally appeared on DailyFinance on Mon, 06 Dec 2010 16:30:00.
Filed Under: Company News, Health Care, Novartis, Stocks in the News